HR

Himani Rajput

Active Director Director DIN 10076553
DIN 10076553 First appointment Mar 2023 Primary industry Life Sciences
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Himani Rajput

Data last updated:

Himani Rajput is a Director at Liefer Biotech Private Limited (since 2023). The company operates in Life Sciences. Liefer Biotech Private Limited reported revenue of ₹25.5 Lakh (FY 2024).

DIN 10076553
Primary Designation Director
Industry Life Sciences
First Appointment 01 Mar 2023
Oldest Company Age 4 yrs
Largest company Liefer Biotech Private Limited · ₹25.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Liefer Biotech Private Limited U51909DL2022PTC402772
Director01 Mar 20232022₹25.5 Lakh (FY 2024)Active

Board colleagues of Himani Rajput

Directorship timeline

Open interactive timeline →
Liefer Biotech Private Limited
Premium access

Shareholding and investment profile for Himani Rajput

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Himani Rajput

Himani Rajput currently holds 1 directorship: Liefer Biotech Private Limited (Director, since 01 Mar 2023, revenue ₹25.5 Lakh (FY 2024)).

Himani Rajput was first appointed on 01 Mar 2023 as Director at Liefer Biotech Private Limited.

The current boards of Himani Rajput's companies include Chitra Rani (Liefer Biotech Private Limited), Manoj Kumar Rajput (Liefer Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available